Lantern Pharma Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | |
| – | – | +108.2% | +2,775.5% | +58.8% | +13.0% | +9.0% | -90.9% | |
| – | -164.0% | – | – | – | – | – | – | |
| – | +66.6% | +135.3% | +237.5% | +113,536.7% | -99.9% | +35.6% | -28.6% | |
| – | +27.8% | +148.5% | +37.0% | +116,010.0% | -99.9% | +1.8% | +6.1% | |
| – | +40.6% | +143.3% | +113.1% | +114,522.9% | -99.9% | +25.5% | -19.1% | |
| – | – | – | – | – | – | – | – | |
| – | – | – | – | -7.8% | – | – | – | |
| – | – | – | – | – | – | – | – | |
| – | -100.2% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.